top of page
Global Regulatory Intelligence
Stay ahead of global regulatory developments in medical devices, pharma, and biotech. Covers FDA, EMA, MHRA, COFEPRIS and international regulatory news for companies in multiple markets.


UK FDA 510k Submission Expert Guidance
Navigating the FDA 510k submission process can be challenging, especially for companies based in the UK aiming to enter the US medical device market. Understanding the regulatory landscape and aligning your submission with FDA expectations is crucial for a smooth approval process. In this article, I will share clear, practical guidance tailored for biotech and SME companies in the medical device and pharmaceutical sectors. My goal is to demystify the FDA 510k submission proce

Camilla Costa
Apr 174 min read


The Shifting Landscape of Global Regulatory Affairs: Key Developments in Early 2026
The first few weeks of 2026 have brought significant developments from the FDA and EMA, from landmark AI collaborations to proactive measures for strengthening domestic manufacturing and securing drug supplies.

Camilla Costa
Jan 253 min read


Essential Advice for Medical Device Compliance with Medical Device Consulting Services
Understanding the Regulatory Landscape with Medical Device Consulting Services. Regulations vary by region, but the core principles remain consistent: safety, efficacy, and quality. For example, in the UK and Europe, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set stringent requirements. In the US, the FDA’s Quality System Regulation (QSR) governs device manufacturing and controls.

Camilla Costa
Dec 23, 20254 min read


Master the Keys to Entering Global Markets Successfully: A Guide to International Market Expansion
A well-structured strategy is the backbone of successful international expansion. It involves thorough market research, competitive analysis, and a clear entry plan. Here are the critical steps to consider:

Camilla Costa
Dec 8, 20254 min read


Navigating the New COFEPRIS Reliance Pathway for Expedited Approvals in Mexico's Pharma Landscape
The pharmaceutical industry in Mexico is on the brink of significant change thanks to the reliance regulatory pathway introduced by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). This new approach is designed to make the approval processes for clinical research protocols

Camilla Costa
Jul 16, 20254 min read
bottom of page